Audio Recording of Earnings Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 2025
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the stock exchanges that the audio recording of its earnings call held on May 22, 2025, discussing audited financial results for Q4 and FY ended March 31, 2025, has been uploaded to the company's website. The filing is a routine regulatory disclosure under SEBI LODR Regulations and does not itself contain the financial details or management commentary. Investors interested in the actual results and management outlook would need to listen to the audio recording linked in the filing.
This is an administrative disclosure with no direct impact on the stock price. The earnings call itself (linked in the filing) is where any meaningful guidance, outlook, or Q&A details would be found, which could influence investor sentiment.